Evidence map›Paper›PMID 32423379›Full record

ReviewBMC medical genetics2020

LARS2-Perrault syndrome: a new case report and literature review.

Maria Teresa Carminho-Rodrigues, Phillipe Klee, Sacha Laurent, Michel Guipponi, Marc Abramowicz, Hélène Cao-van, Nils Guinand, Ariane Paoloni-Giacobino

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in BMC medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maria Teresa Carminho-RodriguesDepartment of Genetic Medicine, University Hospitals of Geneva Rue, Gabrielle-Perret-Gentil 4, 1211, Genève 14, Switzerland. mcih@hcuge.ch.
Phillipe KleeDepartement of Pediatrics endocrinology, Geneva University Hospital, Geneva, Switzerland.
Sacha LaurentDepartment of Genetic Medicine, University Hospitals of Geneva Rue, Gabrielle-Perret-Gentil 4, 1211, Genève 14, Switzerland.
Michel GuipponiDepartment of Genetic Medicine, University Hospitals of Geneva Rue, Gabrielle-Perret-Gentil 4, 1211, Genève 14, Switzerland.
Marc AbramowiczDepartment of Genetic Medicine, University Hospitals of Geneva Rue, Gabrielle-Perret-Gentil 4, 1211, Genève 14, Switzerland.
Hélène Cao-vanDepartement of ENT, Geneva University Hospital, Geneva, Switzerland.
Nils GuinandDepartement of ENT, Geneva University Hospital, Geneva, Switzerland.
Ariane Paoloni-GiacobinoDepartment of Genetic Medicine, University Hospitals of Geneva Rue, Gabrielle-Perret-Gentil 4, 1211, Genève 14, Switzerland.
University of Geneva · CHUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPerrault syndrome is a rare recessive and genetically heterogeneous disorder characterized by sensorineural hearing loss in males and females and gonadal dysgenesis in females. Mutations in seven different genes have been identified: HARS2, HSD17B4, CLLP, C10orf, ERAL1, TWNK and LARS2. To date, 19 variants have been reported in 18 individuals with LARS2-Perrault syndrome. CASE PRESENTATION: Here we describe the case of an 8-year-old girl with compound heterozygous missense mutations in the LARS2 gene. We identified two missense mutations [c.457A > C, p.(Asn153His) and c.1565C > A, p.(Thr522Asn)] and subsequent familial segregation showed that each parent had transmitted a mutation.

conclusionsThese results have implications for genetic counseling and provide insight into the functional role of LARS2. This case highlights the importance of an early diagnosis. Systematic genetic screening of children with hearing loss allows the early identification of a Perrault syndrome in order to ensure specific endocrinological surveillance and management to prevent secondary complications. Clinical data are compared with the other cases reported in the literature.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseMutationAllelesAmino Acid SubstitutionAmino Acyl-tRNA SynthetasesBiomarkersChildDisease ManagementFemaleGenotypeGonadal Dysgenesis, 46,XXHearing Loss, SensorineuralHumansPhenotypeAmino Acyl-tRNA SynthetasesBiomarkersLARS2 protein, humanLARS2Perrault syndromeSensorineural hearing lossWhole-exome sequencing

Identifiers

PMID32423379
PMCPMC7236518
OpenAlexW3027279488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.